Human Cytomegalovirus Infection Enhances NK Cell Activity In Vitro.

Détails

Ressource 1Télécharger: 27830183_BIB_59D546BAA9DC.pdf (481.15 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY-NC-ND 4.0
ID Serval
serval:BIB_59D546BAA9DC
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Human Cytomegalovirus Infection Enhances NK Cell Activity In Vitro.
Périodique
Transplantation direct
Auteur⸱e⸱s
Tschan-Plessl A., Stern M., Schmied L., Retière C., Hirsch H.H., Garzoni C., van Delden C., Boggian K., Mueller N.J., Berger C., Villard J., Manuel O., Meylan P., Terszowski G.
ISSN
2373-8731 (Print)
ISSN-L
2373-8731
Statut éditorial
Publié
Date de publication
07/2016
Peer-reviewed
Oui
Volume
2
Numéro
7
Pages
e89
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: epublish
Résumé
Occurring frequently after solid organ and hematopoietic stem cell transplantation, cytomegalovirus (CMV) replication remains a relevant cause of mortality and morbidity in affected patients. Despite these adverse effects, an increased alloreactivity of natural killer (NK) cells after CMV infection has been assumed, but the underlying physiopathological mechanisms have remained elusive.
We used serial analyses of NK cells before and after CMV infection in kidney transplant recipients as an in vivo model for CMV primary infection to explore the imprint of CMV infection using every patient as their own control: We analyzed NK cell phenotype and function in 47 CMV seronegative recipients of CMV seropositive kidney grafts, who developed CMV primary infection posttransplant. Seronegative recipients of seronegative kidney grafts served as controls.
We observed a significant increase of NKG2C expressing NK cells after CMV infection (mean increase, 17.5%; 95% confidence interval [95% CI], 10.2-24.9, P < 0.001), whereas cluster of differentiation (CD)57 expressing cells decreased (mean decrease, 14.1%; 95% CI, 8.0-20.2; P < 0.001). Analysis of killer immunoglobulin-like receptor (KIR) expression showed an increase of cells expressing KIR2DL1 as their only inhibitory KIR in patients carrying the cognate ligand HLA-C2 (mean increase, 10.0%; 95% CI, 1.7-18.3; P = 0.018). In C2-negative individuals, KIR2DL1 expression decreased (mean decrease, 3.9%; 95% CI, 1.6-6.2; P = 0.001). As for activating KIR, there was no conclusive change pattern. Most importantly, we observed a significantly higher NK cell degranulation and IFNγ production in response to different target cells (target K562, CD107a: mean increase, 9.9%; 95% CI, 4.8-15.0; P < 0.001; IFNγ: mean increase, 6.6%; 95% CI, 1.6-11.1; P < 0.001; target MRC-5, CD107a: mean increase, 6.9%; 95% CI, 0.7-13.1; P = 0.03; IFNγ: mean increase, 4.8%; 95% CI, 1.7-7.8; P = 0.002).
We report evidence for an increased function of NK cells induced by CMV infection. This increased in vitro functionality was seen in NKG2C-positive and NKG2C-negative subsets, arguing for an NKG2C independent mechanism of action.
Pubmed
Web of science
Open Access
Oui
Création de la notice
31/07/2019 7:53
Dernière modification de la notice
15/01/2021 8:09
Données d'usage